Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
British Journal of Cancer
|
August 26, 2010
MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
J C Hassel, A Sucker, L Edler, et al.
Investigational New Drugs
|
December 21, 2010
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer
Dirk Strumberg, Beate Schultheis, M E Scheulen, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
June 19, 2010
Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer
D Strumberg, B Schultheis, M E Scheulen, et al.
Pharmacogenetics
|
March 27, 2001
Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility
H Wikman, S Thiel, B Jäger, et al.
The Journal of Investigative Dermatology
|
September 1, 1991
Detection of Epstein-Barr virus-DNA in tongue epithelium of human immunodeficiency virus-infected patients
H Näher, L Gissmann, C von Knebel Doeberitz, et al.
Cancer Letters
|
December 13, 2005
Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy
C Zhang, A Kolb, J Mattern, et al.
The European Respiratory Journal
|
August 1, 2009
Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis
D B Scherf, H Dally, P Müller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2002
Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial
E Laack, T Mende, H Dürk, et al.
British Journal of Cancer
|
November 28, 2007
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
S Steinbild, K Mross, A Frost, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2001
Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial
E Laack, T Mende, J Benk, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
British Journal of Cancer
|
August 26, 2010
MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome
J C Hassel, A Sucker, L Edler, et al.
Investigational New Drugs
|
December 21, 2010
Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer
Dirk Strumberg, Beate Schultheis, M E Scheulen, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
June 19, 2010
Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer
D Strumberg, B Schultheis, M E Scheulen, et al.
Pharmacogenetics
|
March 27, 2001
Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility
H Wikman, S Thiel, B Jäger, et al.
The Journal of Investigative Dermatology
|
September 1, 1991
Detection of Epstein-Barr virus-DNA in tongue epithelium of human immunodeficiency virus-infected patients
H Näher, L Gissmann, C von Knebel Doeberitz, et al.
Cancer Letters
|
December 13, 2005
Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy
C Zhang, A Kolb, J Mattern, et al.
The European Respiratory Journal
|
August 1, 2009
Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis
D B Scherf, H Dally, P Müller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2002
Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial
E Laack, T Mende, H Dürk, et al.
British Journal of Cancer
|
November 28, 2007
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
S Steinbild, K Mross, A Frost, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2001
Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial
E Laack, T Mende, J Benk, et al.
Page
of 13